HomeSearchESMO Open

ESMO Open

Elsevier B.V. · United Kingdom · Est. 1972

ISSN2059-7029eISSN2059-7029
SJR Q1WOS SCIEScopus / SJRDOAJOpen Access
75
/ 100
High Trust
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q1+25
DOAJ Verified+15
Total75
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
3.582
H-Index
94
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
1.982
Total Works
7,325
Total Citations
50,969
2yr Mean Citedness
1.40
Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal publishes research on cancer therapies, including the evaluation of novel drug combinations and targeted treatments for various cancer types such as breast, colorectal, gastric, and urothelial carcinoma. It also covers studies on biomarkers, treatment resistance, and the prediction of outcomes like venous thromboembolism and pathological response. Additionally, the journal addresses aspects of regulatory assessment complexity and health inequalities in cancer care.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
10
weeks to review
Fast · median is 15 wks
Q1
SJR Rank
Top 25% in field

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1972
Annual Volume~ 1,383 articles / year
StatusActive (last: 2026)
Total Publications7,325
Publisher OrgElsevier BV
OA Since2014
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~10 weeks
Acceptance Rate
OA LicenseCC BY, CC BY-NC-ND
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
PorticoPMCCLOCKSS

Think.Check.Submit Compliance

10/12 · 83%
Do you know the journal / publisher?
Elsevier B.V.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2059-7029 / 2059-7029
Indexed in a trusted database?
WoS, Scopus, DOAJ
Peer review process documented?
Single-blind
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
Portico, PMC, CLOCKSS
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1
OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsCancer Treatment and PharmacologyLung Cancer Research StudiesColorectal Cancer Treatments and StudiesLung Cancer Diagnosis and Treatment
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref